Adipocyte-Specific ATAC-Seq with Adipose Tissues Using Fluorescence-Activated Nucleus Sorting
March 17th, 2023
3.1K views
We present a protocol for assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq) specifically on adipocytes using nucleus sorting with adipose tissues isolated from transgenic reporter mice with nuclear fluorescence labeling.
Overview
This article presents a protocol for performing ATAC-seq specifically on adipocytes using nucleus sorting. The method utilizes adipose tissues isolated from transgenic reporter mice with nuclear fluorescence labeling to generate high-quality data.
Key Study Components
Area of Science
- Neuroscience
- Genomics
- Cell Biology
Background
- ATAC-seq is a technique used to study gene expression regulatory mechanisms.
- Adipose tissue presents challenges for ATAC-seq due to lipid content and cellular heterogeneity.
- Fluorescence-activated nucleus sorting helps minimize mitochondrial DNA contamination.
- This method can be adapted for other tissues with specific Cre mouse lines.
Purpose of Study
- To develop a reliable ATAC-seq protocol for adipocytes.
- To enhance data quality by reducing contamination.
- To provide a method applicable to various tissues.
Methods Used
- Isolation of adipose tissue from transgenic reporter mice.
- Chilling glass Dounce homogenizers on ice for sample preparation.
- Using a specific NPB mix for nucleus isolation.
- Fluorescence-activated nucleus sorting to obtain high-quality nuclei.
Main Results
- Successful isolation of nuclei from adipocytes with minimal contamination.
- High-quality ATAC-seq data generated from adipose tissues.
- Protocol adaptable for other cell types with nuclear labeling.
- Demonstrated effectiveness of the method in studying gene regulation in adipocytes.
Conclusions
- The developed protocol allows for effective ATAC-seq in adipocytes.
- Minimizing mitochondrial contamination is crucial for data integrity.
- This method can be extended to other tissues, enhancing its utility in research.
Frequently Asked Questions
What is ATAC-seq?
ATAC-seq is a technique used to assess chromatin accessibility and understand gene regulation.
Why is adipose tissue challenging for ATAC-seq?
Adipose tissue has high lipid content and cellular heterogeneity, complicating the analysis.
How does nucleus sorting improve ATAC-seq results?
Nucleus sorting reduces mitochondrial contamination and enhances data quality.
Can this method be used for other tissues?
Yes, it can be adapted for other tissues with specific Cre mouse lines.
What are the key steps in the protocol?
Key steps include tissue isolation, chilling homogenizers, and using NPB mix for nucleus isolation.
What are the main findings of this study?
The study successfully demonstrates a reliable method for ATAC-seq in adipocytes with high-quality data.
Executive Industry Relevance
Cell-type-specific ATAC-seq in adipose tissue addresses a critical bottleneck in chromatin accessibility profiling for metabolic disease research and target validation. By enabling high-fidelity isolation of adipocyte nuclei, this protocol reduces confounding signals from cellular heterogeneity and mitochondrial contamination, supporting more predictive and actionable genomic insights. The approach enhances confidence in regulatory element mapping, directly impacting early discovery and translational research pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables precise interrogation of chromatin accessibility in adipocytes, clarifying regulatory mechanisms underlying metabolic pathways.
- Reduces biological ambiguity by isolating pure adipocyte nuclei, supporting robust functional target validation.
- Improves predictive confidence in linking regulatory elements to gene expression changes relevant to disease models.
Screening & Assay Development
- Provides validated, cell-type-specific chromatin profiles for downstream assay development and screening workflows.
- Facilitates reproducible and quantitative assessment of chromatin states, supporting assay standardization.
- Minimizes wasted sequencing reads and reagent use, increasing operational efficiency for high-throughput studies.
Translational & Preclinical Research
- Aligns chromatin accessibility data with disease-relevant adipocyte biomarkers, supporting translational biomarker discovery.
- Enables continuity from discovery through preclinical validation by providing high-quality, cell-type-resolved epigenomic data.
- Supports risk-adjusted advancement decisions by clarifying mechanistic links between chromatin state and gene regulation in metabolic tissues.
Pipeline & Workflow Integration
This protocol integrates into the discovery-to-preclinical continuum by enabling cell-type-specific chromatin profiling in adipose tissues, supporting both early target validation and translational research.
- Discovery Biology: Supports hypothesis testing and pathway clarification by isolating regulatory elements active in adipocytes.
- Screening: Delivers reproducible, quantitative chromatin accessibility data for assay readiness and compound evaluation.
- Analytics: Provides high signal-to-noise readouts and quantitative enrichment at marker loci, enabling robust statistical comparisons.
- Translational Research: Connects chromatin state changes to disease-relevant gene expression, supporting biomarker alignment.
- Enterprise Reuse: Adaptable to other tissues with nuclear labeling, extending utility across diverse preclinical models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in regulatory genomics.
- Operational Value: Standardizes cell-type-specific ATAC-seq workflows, improving reproducibility and scalability.
- Strategic Value: Enables more informed go/no-go decisions and reduces late-stage biological risk in metabolic disease portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of metabolic and obesity-related targets.
Implementation Considerations
- Requires expertise in nuclear isolation, FACS, and ATAC-seq library preparation.
- Demands access to transgenic reporter mouse lines with nuclear labeling capability.
- Relies on high-quality tissue samples and gentle handling to preserve nucleus integrity.
- Needs robust analytical infrastructure for sequencing and downstream bioinformatics.
- Adaptation to other cell types depends on availability of suitable nuclear labeling systems.
Biopharma FAQs
Why does null hypothesis testing matter for ATAC-seq enrichment analysis?
Null hypothesis testing in ATAC-seq enrichment analysis ensures that observed chromatin accessibility at adipocyte marker loci is statistically significant and not due to background noise. This rigor supports confident target validation and reduces the risk of false positives in regulatory element identification. Reliable statistical thresholds are essential for actionable discovery-stage decisions.
How does independent variable isolation via FACS support the discovery pipeline?
Fluorescence-activated nucleus sorting isolates adipocyte nuclei from heterogeneous adipose tissue, enabling precise attribution of chromatin accessibility changes to specific cell types. This isolation enhances mechanistic clarity and supports robust hypothesis testing in early discovery workflows. It also reduces confounding signals, improving the interpretability of downstream analyses.
What do quantitative dependent variable measurements in ATAC-seq enable?
Quantitative measurements of chromatin accessibility, such as fold enrichment at marker genes and signal-to-noise ratios, enable direct comparison of regulatory activity across conditions and samples. These outputs support reproducible assay development and facilitate cross-study benchmarking. They also inform prioritization of candidate regulatory elements for further validation.
Why are replication requirements critical for cross-functional collaboration in ATAC-seq studies?
Replication ensures that ATAC-seq findings are robust and reproducible across biological samples and experimental runs, which is essential for cross-functional teams to trust and act on the data. Consistent results enable integration with other omics platforms and support collaborative decision-making in target validation and biomarker discovery. High reproducibility also underpins regulatory and translational confidence.
What statistical analysis capabilities are required before implementing adipocyte-specific ATAC-seq?
Implementation requires capabilities for quality control, enrichment analysis, and signal-to-noise assessment, including evaluation of mitochondrial read fraction and nucleosomal peak distribution. Teams must be able to interpret qPCR-based enrichment and sequencing metrics to ensure data quality. These analyses are foundational for reliable downstream biological and translational insights.
Chapters in this video
0:05
Introduction
0:51
Nucleus Isolation
2:15
Nucleus Sorting and Tn5 Tagmentation
4:08
DNA Purification and PCR Amplification
5:32
Real-Time Quantitative PCR (qPCR) Test, Additional PCR Amplification, and Second DNA Purification
6:14
DNA Fragment Size Selection
8:01
Results: Assay for Transposase-Accessible Chromatin with High-Throughput Sequencing
10:19
Conclusion
